Elucidation of the physiologically distinct subunits of troponin in 1973 greatly facilitated our
understanding of cardiac contraction. Although troponins are expressed in both skeletal and …

New biomarkers are being evaluated for their ability to advance the management of patients
with heart failure. Despite a large pool of interesting candidate biomarkers, besides …

Serological assessment of cardiac troponins (cTn) is the gold standard to assess myocardial
injury in clinical practice. A greater magnitude of acutely or chronically elevated cTn …

Cardiac troponin I and cardiac troponin T are nowadays the criterion biomarkers for the
laboratory diagnosis of acute myocardial infarction due to their very high sensitivities and …

Multiple epidemiological studies document that habitual physical activity reduces the risk of
atherosclerotic cardiovascular disease (ASCVD), and most demonstrate progressively lower …

Laboratory diagnosis plays one of the key roles in the diagnosis of many diseases, including
cardiovascular diseases (CVD). The methods underlying the in vitro study of many CVD …

Acute myocardial infarction is defined as myocardial cell death due to prolonged myocardial
ischaemia. Cardiac troponins (cTn) are the most sensitive and specific biochemical markers …

The release of cardiomyocyte components, ie biomarkers, into the bloodstream in higher
than usual quantities indicates an ongoing pathological process. Thus, detection of elevated …

Regular physical exercise is recommended for the primary prevention of cardiovascular
disease. Although the high prevalence of physical inactivity remains a formidable public …

It has been known for 50 years that transaminase activity increases in patients with acute
myocardial infarction. With the development of creatine kinase (CK), biomarkers of cardiac …